{
  "issued_date": "2013-09-05", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON314666", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2013/071", 
    "Audience": "", 
    "Published": "5 September 2013 at 14:00", 
    "Format": "Electronic", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Field Safety Notice", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con295467.pdf", 
      "filename": "downloads/90ebd4d1bcc9ebc090f013f8c125faaf862a9349/con295467.pdf", 
      "original_filename": "con295467.pdf"
    }, 
    {
      "content_type": "image/jpeg", 
      "title": "NordiPen\u00ae", 
      "assetid": 1, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/CON314676.jpg", 
      "filename": "downloads/4db59dcd83471e018623f89f4778a3fe8f069be5/CON314676.jpg", 
      "original_filename": "CON314676.jpg"
    }, 
    {
      "content_type": "image/jpeg", 
      "title": "NordiPenMate\u00ae", 
      "assetid": 2, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/CON314677.jpg", 
      "filename": "downloads/5836ce7a6d62d8cddd8ab07abd689f1e6a0da6ec/CON314677.jpg", 
      "original_filename": "CON314677.jpg"
    }, 
    {
      "content_type": "image/jpeg", 
      "title": "Growth Hormone Pen - How to find the lot number", 
      "assetid": 3, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/CON314678.jpg", 
      "filename": "downloads/67d91426161fe29d6b18cd3cf6f36f17e44bdd93/CON314678.jpg", 
      "original_filename": "CON314678.jpg"
    }
  ], 
  "body": "## Device\n\nGrowth hormone pens.\n\nNordiPen\u00ae used with 5mg and 10mg Norditropin\u00ae SimpleXx\u00ae (\u2018somatropin\u2019) and NordiPenMate\u00ae.\n\nManufactured by Novo Nordisk.\n\n\u00a0\n\nNordiPen\u00ae\n\n![ASSET_TAG](#ASSET1)\n\nNordiPenMate\u00ae\n\n![ASSET_TAG](#ASSET2)\n\nAll devices with a lot number beginning with A or B.\n\nLot numbers beginning with a \u2018C\u2019 are referred to in the July 2013 FSN but they were never distributed by the manufacturer.\n\nHow to find the lot number\n\nThe lot number is located on the mechanical section below the push button and can be exposed by turning the dose selector clockwise.\n\nThe lot number in the example image begins with \u2018B\u2019.\n\n![ASSET_TAG](#ASSET3)\n\n## Problem\n\nThere is a risk of under-dosing as the device may not fully screw together.\n\nA change to the metal screw threads of the mechanical section may cause the user to experience increased resistance during assembly. \u00a0Patients may assume the pen is correctly assembled when it is not, and therefore not receive the correct dose.\n\nThe manufacturer issued [ASSET_TAG](#ASSET0) (352Kb) (FSN) in July and September 2013 advising users of the problem and how to assemble the devices; however, they have received insufficient reconciliation data.\n\n## Action\n\nEnsure that all staff who are responsible for managing patients with these devices are aware of the assembly instructions in the FSNs.\n\nIdentify all patients who use these devices and ensure that they receive the patient letter attached to either FSN explaining how to assemble the devices.\n\nReturn the confirmation of receipt form in the FSNs to the manufacturer.\n\n### Action by\n\nAll medical and nursing staff who use and supply these devices.\n\n## Distribution\n\nThis MDA has been sent to:  \n  \n  * Care Quality Commission (CQC) (headquarters) for information  \n  * Clinical commissioning groups (CCGs)  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * Local authorities in Scotland (equipment coordinators)  \n  * NHS boards and trusts in Wales (chief executives)  \n  * NHS boards in Scotland (equipment coordinators)  \n  * NHS England area teams  \n  * NHS trusts in England (chief executives)  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment.\u00a0  \nBelow is a suggested list of recipients.\n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * Chief pharmacists  \n  * Clinical governance leads  \n  * Community children\u2019s nurses  \n  * Community hospitals  \n  * Community nurses  \n  * District nurses  \n  * Endocrinology units  \n  * Endocrinology, directors of  \n  * Health and safety managers  \n  * Health visitors  \n  * Hospital at home units  \n  * Hospital pharmacies  \n  * Hospital pharmacists  \n  * Medical directors  \n  * Nursing executive directors  \n  * Paediatric medicine, directors of  \n  * Paediatric nurse specialists  \n  * Pharmacists  \n  * Risk managers  \n  \nNHS England area teams  \nCAS liaison officers for onward distribution to all relevant staff including:  \n  \n  * Community pharmacists  \n  * General practitioners  \n  * Practice managers  \n  * Practice nurses  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)\u00a0  \nThis alert should be read by:  \n  \n  * Clinics  \n  * Hospitals in the independent sector  \n  * Independent treatment centres  \n  * Private medical practitioners  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health's Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk)\u00a0and requesting this facility.\n\n## Manufacturer Contact\n\nCustomer Service  \nNovo Nordisk Limited  \nBroadfield Park  \nBrighton Road, Crawley  \nWest Sussex RH11 9RT\n\nTel: 0845 600 5055  \nTel: 01293 611 819\n\nEmail: [NNGB-Safety@novonordisk.com](mailto:NNGB-Safety@novonordisk.com)\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk).\n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2013/069 or 2013/006/025/081/021.\n\nTechnical aspects  \nClaire Dunne and Ainsley Wickens  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel: 020 3080 7162 / 7273  \nFax: 020 8754 3965  \nEmail: [claire.dunne@mhra.gsi.gov.uk](mailto:claire.dunne@mhra.gsi.gov.uk) or [ainsley.wickens@mhra.gsi.gov.uk](mailto:ainsley.wickens@mhra.gsi.gov.uk)\n\nClinical aspects  \nMark Grumbridge  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel: 020 3080 7128  \nFax: 020 8754 3965  \nEmail: [mark.grumbridge@mhra.gsi.gov.uk](mailto:mark.grumbridge@mhra.gsi.gov.uk)\n\n### How to report adverse incidents\n\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found [on the CAS website](https://www.cas.dh.gov.uk/Home.aspx) (external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald BT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link)  \nFurther information about SABS can be found [on the SABS website](http://sabs.dhsspsni.gov.uk/)(external link)\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\n[Incident Reporting and Investigation Centre](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/)  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 3922  \nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n\t\t\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><span>Growth hormone pens.</span></p>\n\n<p><span>NordiPen&#174; used with 5mg and 10mg Norditropin&#174; SimpleXx&#174; (&#8216;somatropin&#8217;) and NordiPenMate&#174;.</span></p>\n\n<p><span>Manufactured by Novo Nordisk.</span></p>\n\n<p>&#160;</p>\n\n<p><span>NordiPen&#174;</span></p>\n\n<p><img src=\"#ASSET1\" alt=\"ASSET_TAG\"></p>\n\n<p><span>NordiPenMate&#174;</span></p>\n\n<p><img src=\"#ASSET2\" alt=\"ASSET_TAG\"></p>\n\n<p>All devices with a lot number beginning with A or B.</p>\n\n<p>Lot numbers beginning with a &#8216;C&#8217; are referred to in the July 2013 FSN but they were never distributed by the manufacturer.</p>\n\n<p><span>How to find the lot number</span></p>\n\n<p>The lot number is located on the mechanical section below the push button and can be exposed by turning the dose selector clockwise.</p>\n\n<p>The lot number in the example image begins with &#8216;B&#8217;.</p>\n\n<p><img src=\"#ASSET3\" alt=\"ASSET_TAG\"></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p>There is a risk of under-dosing as the device may not fully screw together.</p>\n\n<p>A change to the metal screw threads of the mechanical section may cause the user to experience increased resistance during assembly. &#160;Patients may assume the pen is correctly assembled when it is not, and therefore not receive the correct dose.</p>\n\n<p>The manufacturer issued <a href=\"#ASSET0\">ASSET_TAG</a> (352Kb) (FSN) in July and September 2013 advising users of the problem and how to assemble the devices; however, they have received insufficient reconciliation data.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<p>Ensure that all staff who are responsible for managing patients with these devices are aware of the assembly instructions in the FSNs.</p>\n\n<p>Identify all patients who use these devices and ensure that they receive the patient letter attached to either FSN explaining how to assemble the devices.</p>\n\n<p>Return the confirmation of receipt form in the FSNs to the manufacturer.</p>\n\n<h3>Action by</h3>\n\n<p>All medical and nursing staff who use and supply these devices.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to:</p>\n\n<ul>\n<li>Care Quality Commission (CQC) (headquarters) for information</li>\n\n<li>Clinical commissioning groups (CCGs)</li>\n\n<li>HSC trusts in Northern Ireland (chief executives)</li>\n\n<li>Local authorities in Scotland (equipment coordinators)</li>\n\n<li>NHS boards and trusts in Wales (chief executives)</li>\n\n<li>NHS boards in Scotland (equipment coordinators)</li>\n\n<li>NHS England area teams</li>\n\n<li>NHS trusts in England (chief executives)</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment.&#160;<br>\nBelow is a suggested list of recipients.</p>\n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Chief pharmacists</li>\n\n<li>Clinical governance leads</li>\n\n<li>Community children&#8217;s nurses</li>\n\n<li>Community hospitals</li>\n\n<li>Community nurses</li>\n\n<li>District nurses</li>\n\n<li>Endocrinology units</li>\n\n<li>Endocrinology, directors of</li>\n\n<li>Health and safety managers</li>\n\n<li>Health visitors</li>\n\n<li>Hospital at home units</li>\n\n<li>Hospital pharmacies</li>\n\n<li>Hospital pharmacists</li>\n\n<li>Medical directors</li>\n\n<li>Nursing executive directors</li>\n\n<li>Paediatric medicine, directors of</li>\n\n<li>Paediatric nurse specialists</li>\n\n<li>Pharmacists</li>\n\n<li>Risk managers</li>\n</ul>\n\n<p><span>NHS England area teams</span><br>\nCAS liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Community pharmacists</li>\n\n<li>General practitioners</li>\n\n<li>Practice managers</li>\n\n<li>Practice nurses</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p><span>Establishments registered with the Care Quality Commission (CQC) (England only)&#160;</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Clinics</li>\n\n<li>Hospitals in the independent sector</li>\n\n<li>Independent treatment centres</li>\n\n<li>Private medical practitioners</li>\n</ul>\n\n<p>Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health's Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\" added=\"null\">safetyalerts@dh.gsi.gov.uk</a>&#160;and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\t<p>Customer Service<br>\nNovo Nordisk Limited<br>\nBroadfield Park<br>\nBrighton Road, Crawley<br>\nWest Sussex RH11 9RT</p>\n\n<p>Tel: 0845 600 5055<br>\nTel: 01293 611 819</p>\n\n<p>Email: <a href=\"mailto:NNGB-Safety@novonordisk.com\">NNGB-Safety@novonordisk.com</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\" added=\"null\">dts@mhra.gsi.gov.uk</a>.</p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2013/069</span> or <span>2013/006/025/081/021</span>.</p>\n\n<p><span>Technical aspects</span><br>\nClaire Dunne and Ainsley Wickens<br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel: 020 3080 7162 / 7273<br>\nFax: 020 8754 3965<br>\nEmail: <a href=\"mailto:claire.dunne@mhra.gsi.gov.uk\">claire.dunne@mhra.gsi.gov.uk</a> or <a href=\"mailto:ainsley.wickens@mhra.gsi.gov.uk\">ainsley.wickens@mhra.gsi.gov.uk</a></p>\n\n<p><span>Clinical aspects</span><br>\nMark Grumbridge<br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel: 020 3080 7128<br>\nFax: 020 8754 3965<br>\nEmail: <a href=\"mailto:mark.grumbridge@mhra.gsi.gov.uk\">mark.grumbridge@mhra.gsi.gov.uk</a></p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings<br>\nStormont Estate<br>\nDundonald BT4 3SQ</p>\n\n<p>Tel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\" added=\"null\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a> (external link)<br>\nFurther information about SABS can be found <a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\" added=\"null\">Incident Reporting and Investigation Centre</a><br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB</p>\n\n<p>Tel: 0131 275 7575<br>\nFax: 0131 314 0722</p>\n\n<p>Email: <a href=\"mailto:nss.iric@nhs.net\" added=\"null\">nss.iric@nhs.net</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 3922<br>\nEmail: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: NordiPen\u00ae manufactured by Novo Nordisk (MDA/2013/071)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": [
    "general-practice", 
    "paediatrics", 
    "pharmacy"
  ]
}